Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.
about
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility.Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United StatesBaseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilliRevised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies.Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens.Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing.
P2860
Q37661510-3DBE8C09-9F9F-4BF6-AC80-CCC528F5D2A5Q38646905-F495857C-2E4B-41C8-B1BC-153CB0A70EEDQ40746046-F794C7C5-8CAA-4738-8167-F737CFA8E0CBQ40993969-6033476D-F347-49BF-B8E1-D2C58102F3C0Q41028154-1E3643A6-CCB8-442D-A8EA-372D3A122D2CQ41290708-CCC801DF-7920-408B-B429-DF5D3F179F32Q41561992-364F2B72-F709-48CA-B0E5-C3E355218C83Q41687426-097A0124-CCDA-4090-8506-33093F8A6A44Q41958813-ED472A8C-D2A2-424D-92B3-95C47268D05BQ42190018-BC47BA94-569C-437F-8C0D-71B2F0BAF62CQ42797044-B9E69BDD-0911-46F3-967D-15E32BB74521Q43125915-83251F2A-991B-44B1-8871-F52D1C4CB951Q43183372-352186DD-00B9-4271-81F3-BA57F8FE309DQ45223324-5BB25C00-0373-4E2B-BCB7-FE1A72638963Q49789445-25A400D5-FDE3-47FE-9A0A-C011DCFB4A89
P2860
Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@ast
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@en
type
label
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@ast
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@en
prefLabel
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@ast
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@en
P2093
P2860
P356
P1476
Factors influencing broth micr ...... cin, a new glycopeptide agent.
@en
P2093
Beth P Goldstein
Cindy C Knapp
Laura Koeth
Robert P Rennie
Ronald N Jones
Scott B Killian
Thomas R Fritsche
P2860
P304
P356
10.1128/JCM.02411-06
P407
P577
2007-08-01T00:00:00Z